Psychiatry · Roslyn Heights, NY
NPI
1730268913
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
70 Glen Cove Rd Ste 201
Roslyn Heights, NY, 11577
Phone (516) 627-9424
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$459K
4,291 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Jane Perr prescribed most often to Medicare patients was Aripiprazole, with 636 prescriptions and refills. In total Jane Perr wrote 4,291 Medicare prescriptions that cost $459K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-02.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Aripiprazole Generic | 636 | 658 | 51 | $69K |
| Sertraline Hcl Generic | 462 | 520 | 38 | $9,065 |
| Escitalopram Oxalate Generic | 354 | 392 | 38 | $8,843 |
| Lorazepam Generic | 275 | 275 | 39 | $5,452 |
| Risperidone Generic | 210 | 210 | 23 | $8,164 |
| Divalproex Sodium Er Divalproex Sodium | 192 | 192 | 17 | $12K |
| Memantine Hcl Generic | 156 | 156 | 11 | $11K |
| Quetiapine Fumarate Er Quetiapine Fumarate | 156 | 160 | Under 11 | $13K |
| Clonazepam Generic | 148 | 148 | 22 | $2,741 |
| Olanzapine Generic | 142 | 142 | 16 | $9,358 |
| Divalproex Sodium Generic | 127 | 143 | 13 | $7,489 |
| Mirtazapine Generic | 120 | 134 | Under 11 | $3,641 |
| Fluoxetine Hcl Generic | 107 | 111 | Under 11 | $1,475 |
| Lamotrigine Generic | 98 | 98 | Under 11 | $2,106 |
| Quetiapine Fumarate Generic | 65 | 65 | Under 11 | $3,098 |
Brand drugs: 206 claims; generic drugs: 4,085 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Jane Perr were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.